6-30924387-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020442.6(VARS2):​c.2500C>T​(p.Arg834Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000867 in 1,612,612 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R834H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0045 ( 3 hom., cov: 33)
Exomes 𝑓: 0.00048 ( 7 hom. )

Consequence

VARS2
NM_020442.6 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.132

Publications

1 publications found
Variant links:
Genes affected
VARS2 (HGNC:21642): (valyl-tRNA synthetase 2, mitochondrial) This gene encodes a mitochondrial aminoacyl-tRNA synthetase, which catalyzes the attachment of valine to tRNA(Val) for mitochondrial translation. Mutations in this gene cause combined oxidative phosphorylation deficiency-20, and are also associated with early-onset mitochondrial encephalopathies. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2014]
VARS2 Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • combined oxidative phosphorylation defect type 20
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0027604997).
BP6
Variant 6-30924387-C-T is Benign according to our data. Variant chr6-30924387-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 377007.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00453 (690/152380) while in subpopulation AFR AF = 0.0136 (564/41596). AF 95% confidence interval is 0.0126. There are 3 homozygotes in GnomAd4. There are 333 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VARS2NM_020442.6 linkc.2500C>T p.Arg834Cys missense_variant Exon 26 of 30 ENST00000676266.1 NP_065175.4 Q5ST30-1B4E0K6B4DG77
VARS2NM_001167734.2 linkc.2590C>T p.Arg864Cys missense_variant Exon 26 of 30 NP_001161206.1 Q5ST30-4A0A1U9X9B3
VARS2NM_001167733.3 linkc.2080C>T p.Arg694Cys missense_variant Exon 25 of 29 NP_001161205.1 Q5ST30-3B4E0K6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VARS2ENST00000676266.1 linkc.2500C>T p.Arg834Cys missense_variant Exon 26 of 30 NM_020442.6 ENSP00000502585.1 Q5ST30-1

Frequencies

GnomAD3 genomes
AF:
0.00451
AC:
687
AN:
152262
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0135
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00713
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00717
GnomAD2 exomes
AF:
0.00108
AC:
262
AN:
243656
AF XY:
0.000803
show subpopulations
Gnomad AFR exome
AF:
0.0143
Gnomad AMR exome
AF:
0.00105
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000554
Gnomad OTH exome
AF:
0.00132
GnomAD4 exome
AF:
0.000485
AC:
708
AN:
1460232
Hom.:
7
Cov.:
32
AF XY:
0.000427
AC XY:
310
AN XY:
726416
show subpopulations
African (AFR)
AF:
0.0149
AC:
500
AN:
33460
American (AMR)
AF:
0.00212
AC:
95
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52294
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5404
European-Non Finnish (NFE)
AF:
0.0000297
AC:
33
AN:
1111976
Other (OTH)
AF:
0.00126
AC:
76
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
37
74
111
148
185
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00453
AC:
690
AN:
152380
Hom.:
3
Cov.:
33
AF XY:
0.00447
AC XY:
333
AN XY:
74508
show subpopulations
African (AFR)
AF:
0.0136
AC:
564
AN:
41596
American (AMR)
AF:
0.00712
AC:
109
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68028
Other (OTH)
AF:
0.00710
AC:
15
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
35
70
105
140
175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00231
Hom.:
0
Bravo
AF:
0.00670
ESP6500AA
AF:
0.0153
AC:
46
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00120
AC:
141
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 02, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

VARS2-related disorder Benign:1
Jun 14, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.063
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
7.1
DANN
Benign
0.91
DEOGEN2
Benign
0.0039
T;.;.
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.090
N
LIST_S2
Benign
0.75
T;T;T
MetaRNN
Benign
0.0028
T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.32
N;.;.
PhyloP100
-0.13
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-1.6
N;.;N
REVEL
Benign
0.024
Sift
Benign
0.18
T;.;T
Sift4G
Benign
0.10
T;T;T
Polyphen
0.057
B;.;.
Vest4
0.11
MVP
0.055
MPC
0.61
ClinPred
0.0027
T
GERP RS
-0.59
Varity_R
0.12
gMVP
0.30
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142520878; hg19: chr6-30892164; API